K. Kuroshima

发表

Design and synthesis of a novel series of orally active, selective somatostatin receptor 2 agonists for the treatment of type 2 diabetes.

J. Kunitomo, Masanori Watanabe, N. Amano, 2017, Bioorganic & medicinal chemistry.

Stimulation of thrombopoiesis in mice by fibroblast growth factor 9.

T. Kondo, T. Kurokawa, A. Shino, 1995, Growth factors.

Novel secretory heparin-binding factors from human glioma cells (glia-activating factors) involved in glial cell growth. Purification and biological properties.

T. Kurokawa, R. Sasada, K. Naruo, 1993, The Journal of biological chemistry.

Genesis and diagenesis of travertine, Futamata hot spring, Japan

F. Shiraishi, Chuan‐Chou Shen, T. Yu, 2020 .

Construction of a sensitive enzyme immunoassay for human fibroblast growth factor 9.

T. Kurokawa, K. Kuroshima, S. Matsumoto-Yoshitomi, 1996, Hybridoma.

Purification and gene cloning of a chitosanase from Bacillus ehimensis EAG1.

A. Yokota, T. Sakane, R. Takata, 1999, Journal of bioscience and bioengineering.

Autocrine transformation by fibroblast growth factor 9 (FGF‐9) and its possible participation in human oncogenesis

T. Kurokawa, K. Kuroshima, S. Matsumoto-Yoshitomi, 1997, International journal of cancer.

Bacillus ehimensis sp. nov. and Bacillus chitinolyticus sp. nov., New Chitinolytic Members of the Genus Bacillus

A. Yokota, T. Sakane, R. Takata, 1996 .

An improved colorimetric assay for interleukin 2.

M. Koyama, H. Tada, O. Shiho, 1986, Journal of immunological methods.